Is heparin administered prefilter in Continuous Renal Replacement Therapy (CRRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Heparin Administration in CRRT: Prefilter vs. Postfilter

Heparin is administered prefilter (before the blood enters the filter) in Continuous Renal Replacement Therapy (CRRT) to maximize anticoagulation effect and prevent filter clotting. 1

Anticoagulation Principles in CRRT

  • Systemic anticoagulation with heparin (standard unfractionated, low-molecular-weight, or synthetic heparinoids) is commonly used in CRRT when patients do not have increased bleeding risk 1
  • Prefilter administration of heparin allows the anticoagulant to immediately mix with the blood before it enters the filter, optimizing the anticoagulant effect throughout the entire extracorporeal circuit 1
  • The choice of anticoagulant should be determined by patient characteristics, local expertise, ease of monitoring, and pharmacy considerations 1

Monitoring Heparin Anticoagulation

  • When using prefilter heparin, safety monitoring is recommended through measurement of activated clotting times (ACT) or systemic partial thromboplastin time (PTT) 1
  • ACT values greater than 218 seconds measured 10 minutes after the initial heparin bolus have been shown to predict 48-hour filter survival 2
  • Routine measurement of platelets should be performed to monitor for heparin-induced thrombocytopenia 1

Alternative Anticoagulation Approaches

  • For patients with high bleeding risk, regional citrate anticoagulation is preferred over heparin when there are no contraindications for citrate 1, 3
  • Regional citrate anticoagulation requires frequent measurements of post-filter and serum-ionized calcium to appropriately titrate the dose of citrate and calcium replacement solutions 1, 4
  • In patients who are auto-anticoagulated or at high risk of bleeding, CRRT can be performed without anticoagulation, although circuit life may be less than 24 hours 1, 5

Clinical Considerations

  • Venovenous therapies are preferred to arteriovenous therapies due to the ability to provide higher rates of solute clearance and reduced risk of complications 1
  • In patients with heparin-induced thrombocytopenia (HIT), all heparin must be stopped, and direct thrombin inhibitors (such as argatroban) or Factor Xa inhibitors should be used instead 1, 3
  • Saline flushes can be an effective alternative to maintain extracorporeal circuit patency in patients with already elevated aPTT (>55 seconds), resulting in significantly fewer bleeding episodes 5

Practical Implementation

  • Prefilter D5W administration can enhance the achievable ultrafiltration rate, which is especially important in high-volume CVVH and can be useful in patients with frequent filter clotting 6
  • When using regional citrate anticoagulation, monitoring of systemic acid-base balance is advisable, particularly in patients at high risk for citrate accumulation 1, 4
  • Standardized anticoagulation administration and monitoring protocols are essential for safe implementation of any anticoagulation strategy in CRRT 3, 4

Remember that the primary goal of anticoagulation in CRRT is to maintain filter patency while minimizing the risk of bleeding complications, and prefilter administration of heparin helps achieve this balance.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Is 10 min post heparin bolus ACT, alongside aPTT monitoring, predictive for CRRT filter survival?

European review for medical and pharmacological sciences, 2022

Guideline

Anticoagulation for Pediatric Continuous Renal Replacement Therapy (CRRT)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prevention of Citrate Toxicity in CRRT

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2010

Guideline

Calculating Prefilter D5W Rate for Hyponatremic Patient on CRRT

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.